Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

May 24, 2013

ELI LILLY AND COMPANY et al v. PERRIGO COMPANY et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 23, 2016

    Judge Nixes Eli Lilly's Axiron Patents In Win For Generics

    A federal judge on Monday largely shut down Eli Lilly & Co.'s patent suit aiming to block generic versions of its testosterone drug Axiron, ruling that three of the four accused generics makers either did not infringe the company's patents or proved them to be invalid.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login